CrunchBase is hiring! Check out our open positions →

Exit
edit

General Information
edit

Corporate Headquarters

520 FairView Avenue N
Suite 2000
Seattle, WA, 98109
USA

Chief Medical Officer

TOTAL	$88.8M
FUNDING TOTAL	$88.8M
Series B, 6/07 Draper Fisher Jurvetson (DFJ) OVP Venture Partners	$8.5M
Series C, 6/09 Clarus Ventures OVP Venture Partners Draper Fisher Jurvetson (DFJ)	$30M
Venture Round, 2/10 Clarus Ventures	$15M
Series D, 11/11 GE Healthcare BioMed Ventures Clarus Ventures Draper Fisher Jurvetson (DFJ) OVP Venture Partners	$20M
Series E, 12/12 Morgan Stanley Expansion Capital AllianceBernstein Clarus Ventures Draper Fisher Jurvetson (DFJ) OVP Venture Partners GE Healthymagination Fund BioMed Ventures	$15.3M
DEBT TOTAL	$15M
Debt, 4/12 Oxford Finance Corporation Silicon Valley Bank	$15M

Life sciences company researching technologies in the expression profiling field. Located in Seattle, WA.

Went public with stock symbol NASDAQ:NSTG. (5/20/13)

Posted 5/20/13 at 8:36pm
NanoString Technologies received $15.3M in Series E funding. (12/3/12)

Posted 12/3/12 at 8:03pm via reuters.com
NanoString Technologies received $15M in Debt funding. (4/3/12)

Posted 4/3/12 at 7:26pm via dowjones.com
NanoString Technologies received $20M in Series D funding. (11/7/11)

Posted 11/7/11 at 5:45am via xconomy.com
NanoString Technologies received $15M in Venture Round funding. (2/12/10)

Posted 7/20/10 at 7:02pm
NanoString Technologies received $30M in Series C funding. (6/14/09)

Posted 6/16/09 at 8:56am via freshnews.com
NanoString Technologies received $8.5M in Series B funding. (6/26/07)

Posted 3/15/10 at 7:38pm via venturebeat.com
NanoString Technologies added J. Wayne Cowens as Chief Medical Officer.

Posted 2/2/11 at 4:19am